Library
3,4-КТМП
3,4-Dichloromethylphenidate (also known by the incorrectly abbreviated name 3,4-CTMP) is a stimulant substance of the phenidate class. It is a structural analog of methylphenidate (Ritalin). The two substances have similar pharmacological profiles but different subjective effects.
Also known as: 3,4-dichloromethylphenidate, 3,4-DCMP
Classification
- Chemical: Phenidate
- Psychoactive: Stimulant
- Tag: Habit-Forming
- Tag: Research-Chemical
- Tag: substituted phenidate
Effects
- Increased Energyalertness
- Decreased Need For Sleep
- Decreased Appetite
- Weight Loss
- Sweating
- Disturbed Sleep Patterns
- Euphoria
- Increased Sociability
- Mood Lift
- Excessive Talking
- Aggressiveness
- Moodiness
- Increased Sexuality
- Visual And Auditory Hallucinations
- Double Vision
- Dehydration
- Disinhibition
- Appetite Suppression
Routes of Administration
Oral
Dosage
- Common: 4-6 mg
- Heavy: 6-10 mg
- Light: 2-4 mg
- Threshold: 1-2 mg
- Strong: 6-8 mg
Duration
- Onset: 1-2 h
- After Effects: 2-24 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.